BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21740499)

  • 1. EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function.
    Clements A; Smollett K; Lee SF; Hartland EL; Lowe M; Frankel G
    Cell Microbiol; 2011 Sep; 13(9):1429-39. PubMed ID: 21740499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic Escherichia coli Hijacks GTPase-Activated p21-Activated Kinase for Actin Pedestal Formation.
    Singh V; Davidson A; Hume PJ; Koronakis V
    mBio; 2019 Aug; 10(4):. PubMed ID: 31431554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and distribution of EspG2, a type III secretion system effector of enteropathogenic Escherichia coli.
    Smollett K; Shaw RK; Garmendia J; Knutton S; Frankel G
    Microbes Infect; 2006 Jul; 8(8):2220-7. PubMed ID: 16781180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Type III Secretion System of Pathogenic Escherichia coli.
    Slater SL; Sågfors AM; Pollard DJ; Ruano-Gallego D; Frankel G
    Curr Top Microbiol Immunol; 2018; 416():51-72. PubMed ID: 30088147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional studies indicate that the EPEC effector, EspG, directly binds p21-activated kinase.
    Germane KL; Spiller BW
    Biochemistry; 2011 Feb; 50(6):917-9. PubMed ID: 21235237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of host cytoskeleton function by the enteropathogenic Escherichia coli and Citrobacter rodentium effector protein EspG.
    Hardwidge PR; Deng W; Vallance BA; Rodriguez-Escudero I; Cid VJ; Molina M; Finlay BB
    Infect Immun; 2005 May; 73(5):2586-94. PubMed ID: 15845460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of Ibe, a novel type III effector protein of A/E pathogens targeting human IQGAP1.
    Buss C; Müller D; Rüter C; Heusipp G; Schmidt MA
    Cell Microbiol; 2009 Apr; 11(4):661-77. PubMed ID: 19134119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-type creatine kinase BB-CK interacts with the Golgi Matrix Protein GM130 in early prophase.
    Bürklen TS; Hirschy A; Wallimann T
    Mol Cell Biochem; 2007 Mar; 297(1-2):53-64. PubMed ID: 17036164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enterohemorrhagic Escherichia coli effector protein NleF binds mammalian Tmp21.
    Olsen RL; Echtenkamp F; Cheranova D; Deng W; Finlay BB; Hardwidge PR
    Vet Microbiol; 2013 May; 164(1-2):164-70. PubMed ID: 23434013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterohaemorrhagic Escherichia coli inhibits recycling endosome function and trafficking of surface receptors.
    Clements A; Stoneham CA; Furniss RC; Frankel G
    Cell Microbiol; 2014 Nov; 16(11):1693-705. PubMed ID: 24898821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding to Na(+) /H(+) exchanger regulatory factor 2 (NHERF2) affects trafficking and function of the enteropathogenic Escherichia coli type III secretion system effectors Map, EspI and NleH.
    Martinez E; Schroeder GN; Berger CN; Lee SF; Robinson KS; Badea L; Simpson N; Hall RA; Hartland EL; Crepin VF; Frankel G
    Cell Microbiol; 2010 Dec; 12(12):1718-31. PubMed ID: 20618342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability.
    Matsuzawa T; Kuwae A; Abe A
    Infect Immun; 2005 Oct; 73(10):6283-9. PubMed ID: 16177299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterohaemorrhagic E. coli modulates an ARF6:Rab35 signaling axis to prevent recycling endosome maturation during infection.
    Furniss RC; Slater S; Frankel G; Clements A
    J Mol Biol; 2016 Aug; 428(17):3399-407. PubMed ID: 27261256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri.
    Elliott SJ; Krejany EO; Mellies JL; Robins-Browne RM; Sasakawa C; Kaper JB
    Infect Immun; 2001 Jun; 69(6):4027-33. PubMed ID: 11349072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structurally distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to counteract host defenses.
    Dong N; Zhu Y; Lu Q; Hu L; Zheng Y; Shao F
    Cell; 2012 Aug; 150(5):1029-41. PubMed ID: 22939626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.
    Wong AR; Pearson JS; Bright MD; Munera D; Robinson KS; Lee SF; Frankel G; Hartland EL
    Mol Microbiol; 2011 Jun; 80(6):1420-38. PubMed ID: 21488979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F
    Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the interaction between the Golgi reassembly-stacking protein GRASP65 and the Golgi matrix protein GM130.
    Hu F; Shi X; Li B; Huang X; Morelli X; Shi N
    J Biol Chem; 2015 Oct; 290(44):26373-82. PubMed ID: 26363069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type III secretion system effector EspO of enterohaemorrhagic Escherichia coli inhibits apoptosis through an interaction with HAX-1.
    Chatterjee S; Lekmeechai S; Constantinou N; Grzybowska EA; Kozik Z; Choudhary JS; Berger CN; Frankel G; Clements A
    Cell Microbiol; 2021 Sep; 23(9):e13366. PubMed ID: 34021690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.